Actual Medicinal Product (AMP) Doralese Tiltab 20mg tablets (Dowelhurst Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Doralese Tiltab 20mg tablets (Chemidex Pharma Ltd) and Indoramin 20mg tablets (Brown & Burk UK Ltd).

Generic

Indoramin

Formulation

Indoramin 20mg tablets

Alternative Suppliers (20)

Doralese Tiltab 20mg tablets (Essential Generics Ltd)

Indoramin 20mg tablets (A A H Pharmaceuticals Ltd)

Indoramin 20mg tablets (Sigma Pharmaceuticals Plc)

Doralese Tiltab 20mg tablets (Lexon (UK) Ltd)

Indoramin 20mg tablets (Phoenix Healthcare Distribution Ltd)

Indoramin 20mg tablets (DE Pharmaceuticals)

Indoramin 20mg tablets (Essential Generics Ltd)

Indoramin 20mg tablets (Medihealth (Northern) Ltd)

Indoramin 20mg tablets (Brown & Burk UK Ltd)

Indoramin 20mg tablets (Alliance Healthcare (Distribution) Ltd)

Indoramin 20mg tablets (Viatris UK Healthcare Ltd)

Indoramin 20mg tablets (Kent Pharma (UK) Ltd)

Doralese Tiltab 20mg tablets (Waymade Healthcare Plc)

Doralese Tiltab 20mg tablets (Dowelhurst Ltd)

Doralese Tiltab 20mg tablets (Sigma Pharmaceuticals Plc)

Doralese Tiltab 20mg tablets (Mawdsley-Brooks & Company Ltd)

Doralese Tiltab 20mg tablets (DE Pharmaceuticals)

Indoramin 20mg tablets (Almus Pharmaceuticals Ltd)

Indoramin 20mg tablets (Waymade Healthcare Plc)

Indoramin 20mg tablets (Mawdsley-Brooks & Company Ltd)

Related Formulations (2)

Indoramin 20mg tablets

Indoramin 25mg tablets